Australia's most trusted
source of pharma news
Friday, 01 May 2026
Posted 1 May 2026 PM
News that Organon has been bought by Indian generics giant Sun Pharma creating a new company that will join the top ranks of industry was our top story this week.
Once the deal goes through the new Top 25 pharma will boast a footprint in 150 countries with 18 large markets expected to generate more than US$100 million a year in revenue. It's a big win for shareholders too. Find out why in: Big Pharma goes under the hammer

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.